Code | CSB-RA176322A0HU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
IHC | 1:50-1:200 |
FC | 1:50-1:200 |
In the production of the KRT20 recombinant monoclonal antibody, in vitro expression systems are employed, involving the cloning of KRT20 antibody DNA sequences from immunoreactive rabbits. The immunogen used is a synthesized peptide derived from the human KRT20 protein. Subsequently, the genes encoding the KRT201 antibodies are inserted into plasmid vectors, and these recombinant plasmid vectors are then transfected into host cells to enable antibody expression. Post-expression, the KRT20 recombinant monoclonal antibody undergoes purification through affinity chromatography. It is thoroughly tested for functionality in ELISA, IHC, and FC applications, demonstrating reactivity with the human KRT20 protein during these evaluations.
The main role of KRT20 protein is to provide structural support and integrity to epithelial tissues, particularly in the gastrointestinal tract. KRT20 also serves as a tissue-specific marker and can be involved in diagnostic applications, especially in the context of certain types of cancers and pathological conditions affecting epithelial tissues.
There are currently no reviews for this product.